Silence Therapeutics (SLN) Share-based Compensation (2024 - 2026)
Silence Therapeutics' Share-based Compensation was $1.31 million in the quarter ended Jun 30, 2026, down 37.3% from $2.09 million a year earlier and down 46.5% from the prior quarter.
Silence Therapeutics (SLN) Share-based Compensation (2024 - 2026) Analysis & Trends
On a trailing twelve-month basis, Silence Therapeutics' Share-based Compensation was $6.2 million through Jun 30, 2026, down 54.6% year-over-year; for the year ended Dec 31, 2025, it came in at $8.07 million, down 50.5% from the prior year.
- Share-based Compensation shows a five-year compound annual growth rate of 7.4% (years ended Dec 2020 to Dec 2025).
- In earlier years, Share-based Compensation was $16.31 million in the year ended Dec 31, 2024 (+0.2%), $16.27 million in the year ended Dec 31, 2023 (+28.3%), $12.69 million in the year ended Dec 31, 2022 (+6.8%) and $11.88 million in the year ended Dec 31, 2021 (+110.4%).
- Quarterly Share-based Compensation has moved between -$86,000 (the quarter ended Dec 31, 2025) and $4.14 million (the quarter ended Jun 30, 2024) over five years.
- Per Business Quant data, SLN's Share-based Compensation in the three quarters before the quarter ended Jun 30, 2026 was $2.45 million (quarter ended Mar 31, 2026), -$86,000 (quarter ended Dec 31, 2025) and $2.54 million (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Silence Therapeutics | 932.92 Mn | 860.82 Mn | - | 1.31 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Mn |
| Mar 31, 2026 | 2.45 Mn |
| Dec 31, 2025 | -86,000.00 |
| Sep 30, 2025 | 2.54 Mn |
| Jun 30, 2025 | 2.09 Mn |
| Mar 31, 2025 | 3.54 Mn |
| Dec 31, 2024 | 3.98 Mn |
| Sep 30, 2024 | 4.07 Mn |
| Jun 30, 2024 | 4.14 Mn |
| Mar 31, 2024 | 4.12 Mn |
Silence Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "SLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();